NINA Medical

Non-invasive Solution for Men with an Enlarged Prostate (BPH)

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in January 2019 by Shmuel Ben-Ezra, Yoni Hertzberg, and Alex Volovick, NINA Medical operates with 1–10 employees. The company has raised $3.67 million across nine funding rounds. In September 2025, NINA Medical secured a Seed funding round led by.

Business overview

NINA Medical is a Health Tech & Life Sciences company focused on developing a non-invasive treatment for Benign Prostatic Hyperplasia (BPH), a common prostate enlargement in aging men. The company's core technology utilizes ultrasound to enable both imaging and treatment of BPH within a urologist's office, offering a non-invasive alternative to traditional procedures. NINA Medical aims to facilitate early intervention and improve patient comfort, serving the digital healthcare, medical devices, and urology sectors.

Strategic signal

NINA Medical is advancing its non-invasive BPH treatment, with plans for its first-in-human clinical trial at Rambam Medical Center in Haifa, followed by a US trial. This development signals a significant step towards commercialization and market validation for its ultrasound-based technology, potentially transforming men's health by offering a safer, more comfortable alternative to invasive procedures and encouraging earlier treatment.

Log in to access full profile

Company Intelligence Q&A

What is NINA Medical's primary focus?
NINA Medical is focused on pioneering a non-invasive treatment for Benign Prostatic Hyperplasia (BPH), a common prostate enlargement in aging men, using ultrasound technology.
When was NINA Medical founded and by whom?
NINA Medical was founded in January 2019 by Shmuel Ben-Ezra, Yoni Hertzberg, and Alex Volovick.
What was the most recent funding event for NINA Medical?
In September 2025, NINA Medical secured a Seed funding round led by.
What is the status of NINA Medical's clinical trials?
NINA Medical is preparing for its first-in-human clinical trial at Rambam Medical Center in Haifa, with plans for a US trial, following successful animal trials and a preliminary clinical study involving 20 patients.
Which investors have supported NINA Medical?
NINA Medical has received support from investors including Rafael Holdings and NGT3.
Log in to access full profile